Preoperative chemotherapy with a modified docetaxel, cisplatin, and S-1 regimen, followed by gastrectomy and lymphadenectomy for gastric cancer with bulky lymph nodes
Preoperative chemotherapy with a modified DCS regimen demonstrated high tolerance, a clinical response rate, and satisfactory 3 year survival outcomes. Thus, a preoperative modified DCS regimen with 3-4 cycles is a promising approach for GC with bulky LNs.
Authors
- Vo Duy Long (ORCID: https://orcid.org/0000-0002-7088-5532)
- Tran Quang Dat
- Doan Thuy Nguyen (ORCID: https://orcid.org/0009-0005-3058-3416)
- Dang Quang Thong (ORCID: https://orcid.org/0000-0003-1206-8881)
- Tran D. Tho
- Nguyen Lam Vuong (ORCID: https://orcid.org/0000-0003-2684-3041)
- Nguyễn Hoàng Bắc (ORCID: https://orcid.org/0000-0002-2973-7909)
- Lam Quoc Trung
- Nguyen Viet Haı
- Tran Duy Phuoc
Institutions
- Ho Chi Minh City University of Science (VN)
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- University Medical Center HCMC (VN)
Publication Details
- Journal
- Surgery Today
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1007/s00595-025-03114-x
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00